Traumatic brain injury may up risk for developing comorbidities

Traumatic brain injury (TBI) of any severity is associated with increased risk of chronic cardiovascular, endocrine, and neurologic comorbidities, according to a study published online April 28 in&nbs

Updated on: February 03,2024 13

Traumatic brain injury may up risk for developing comorbidities

Traumatic brain injury (TBI) of any severity is associated with increased risk of chronic cardiovascular, endocrine, and neurologic comorbidities, according to a study published online April 28 in&nbs

Updated on:February 03,2024 13

Chaperone protein imbalance promotes toxic tau buildup in the aging brain

by University of South FloridaTau pathology resembling that seen in Alzheimer's disease brains. Credit: Laura Blair's laboratory, USF Health/University of South FloridaChaperone protein i

Updated on: April 25,2024 10

Chaperone protein imbalance promotes toxic tau buildup in the aging brain

by University of South FloridaTau pathology resembling that seen in Alzheimer's disease brains. Credit: Laura Blair's laboratory, USF Health/University of South FloridaChaperone protein i

Updated on:April 25,2024 10

Researchers find unanticipated complexity in aging brain's memory decline

by Stephen Fontenot,University of Texas at DallasSabina Srokova Ph.D. and Dr. Michael Rugg, director of the Center for Vital Longevity. Credit: University of Texas at DallasResearchers from The

Updated on: March 28,2024 0

Researchers find unanticipated complexity in aging brain's memory decline

by Stephen Fontenot,University of Texas at DallasSabina Srokova Ph.D. and Dr. Michael Rugg, director of the Center for Vital Longevity. Credit: University of Texas at DallasResearchers from The

Updated on:March 28,2024 0

Nicotinic acetylcholine receptors in the pathophysiology of Alzheimer's disease

by Bentham Science PublishersNicotinic acetylcholine receptors (nAChRs) have been pursued for decades as potential molecular targets to treat cognitive dysfunction in Alzheimer's disease (AD) due

Updated on: March 07,2024 15

Nicotinic acetylcholine receptors in the pathophysiology of Alzheimer's disease

by Bentham Science PublishersNicotinic acetylcholine receptors (nAChRs) have been pursued for decades as potential molecular targets to treat cognitive dysfunction in Alzheimer's disease (AD) due

Updated on:March 07,2024 15

3D imaging helps to better understand the early stages of Alzheimer's disease

by Karolinska InstitutetNoradrenergic neurons of the human locus coeruleus shell in three dimension. Credit: Gilvesy et al.Using a novel 3D imaging technology, researchers at Karolinska Institute

Updated on: March 13,2024 18

3D imaging helps to better understand the early stages of Alzheimer's disease

by Karolinska InstitutetNoradrenergic neurons of the human locus coeruleus shell in three dimension. Credit: Gilvesy et al.Using a novel 3D imaging technology, researchers at Karolinska Institute

Updated on:March 13,2024 18

Synapse discovery could lead to new treatments for Alzheimer's disease

by University of New South WalesDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A team of researchers led by UNSW Australia scientists has discovere

Updated on: February 27,2024 16

Synapse discovery could lead to new treatments for Alzheimer's disease

by University of New South WalesDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A team of researchers led by UNSW Australia scientists has discovere

Updated on:February 27,2024 16

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39

Updated on: May 20,2024 7

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39

Updated on:May 20,2024 7

Neuroscientists uncover important thinning mechanism that affects how the brain matures in adolescence

byUniversity of MontrealCredit: CC0 Public DomainWhat determines how a teenager's brain is structured and how it evolves? In a scientific first, researchers led by Université de Montréal neu

Updated on: January 12,2024 17

Neuroscientists uncover important thinning mechanism that affects how the brain matures in adolescence

byUniversity of MontrealCredit: CC0 Public DomainWhat determines how a teenager's brain is structured and how it evolves? In a scientific first, researchers led by Université de Montréal neu

Updated on:January 12,2024 17

Scientists compete to make best predictions about pertussis vaccine

by La Jolla Institute for ImmunologyGraphical abstract. Credit:Cell Reports Methods(2024). DOI: 10.1016/j.crmeth.2024.100731Scientists love a challenge. Or a friendly competition. Now

Updated on: March 19,2024 19

Scientists compete to make best predictions about pertussis vaccine

by La Jolla Institute for ImmunologyGraphical abstract. Credit:Cell Reports Methods(2024). DOI: 10.1016/j.crmeth.2024.100731Scientists love a challenge. Or a friendly competition. Now

Updated on:March 19,2024 19

Call it Mighty Mouse: Breakthrough leaps Alzheimer's research hurdle

by University of California, IrvineThe reserchers, led by Mathew Blurton-Jones, associate professor of neurobiology & behavior, said the breakthrough also holds promise for investigating many

Updated on: May 06,2024 20

Call it Mighty Mouse: Breakthrough leaps Alzheimer's research hurdle

by University of California, IrvineThe reserchers, led by Mathew Blurton-Jones, associate professor of neurobiology & behavior, said the breakthrough also holds promise for investigating many

Updated on:May 06,2024 20

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on: March 30,2024 14

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on:March 30,2024 14

Survey shows lack of brain health awareness among women

by Cleveland ClinicCredit: Cleveland ClinicNearly two-thirds of Americans with Alzheimer's disease are women, but according to a Women's Alzheimer's Movement at Cleveland Clinic surve

Updated on: May 22,2024 3

Survey shows lack of brain health awareness among women

by Cleveland ClinicCredit: Cleveland ClinicNearly two-thirds of Americans with Alzheimer's disease are women, but according to a Women's Alzheimer's Movement at Cleveland Clinic surve

Updated on:May 22,2024 3